News & Views

  • Technology Deal Could Improve Drug Candidate Potential

Technology Deal Could Improve Drug Candidate Potential

Apr 07 2018 Read 964 Times

Strasbourg, (France) and Quebec-based biopharmaceutical company Domain Therapeutics, which specialises in developing drug candidates targeting transmembrane receptors, has signed a licensing agreement for its bioSens-All™ technology with global business Bristol-Myers Squibb, a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. The deal included an upfront payment for access to the technology, with additional payments on identification of development candidates.

“Through the work done using the technology on a wide variety of targets and in a wide range of indications, this agreement will fit well with its goal of delivering innovative medicines in key disease areas,” said Pascal Neuville, chief executive officer of Domain Therapeutics. “By generating a better understanding of what happens when a molecule binds to a target, we believe that bioSens-All™ is a key platform for improved candidate identification and reduced early stage attrition.”
The technology generates and analyses signalling data on G protein-couple receptors (GPCRs) drug candidates, potentially accelerating the discovery and development of biased drugs. It can monitor several dozen signalling pathways, in living cells, in parallel assays and in a homogeneous format. This allows the link to be made between specific signalling signatures of drug candidates and their biological effects.

Reader comments

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post a Comment

Digital Edition

LabAsia Buyers Guide 2019

October 2019

In This Edition Chromatography - Vacuum Ultraviolet Spectroscopy: A Versatile Tool for Analysis of Gasoline and Jet Fuels - High-performance Columns and Bulk for your Chromatography - New L...

View all digital editions



Oct 22 2019 Cologne, Germany

Chem Show 2019

Oct 22 2019 New York, USA

BCEIA 2019

Oct 23 2019 Beijing, China

Lab Innovations 2019

Oct 30 2019 Birmingham, UK

SETAC North America

Nov 03 2019 Toronto, Canada

View all events